Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon retreats after earnings miss, Provenge warning
The Fly on the Wall
Friday, August 9, 2013 - 1:05pm
tags:
Dendreon, earnings, Provenge
Salix Pharma Stock Falls On Earnings, Guidance Miss
Investors.com
Friday, August 9, 2013 - 1:04pm
tags:
earnings, Salix
Arena's Week 8 Sales Modestly Up
Seeking Alpha
Friday, August 9, 2013 - 12:17pm
tags:
Arena Pharmaceuticals, Belviq, Eisai
Vivus' Qsymia Sales Take A Dip
Seeking Alpha
Friday, August 9, 2013 - 12:16pm
tags:
Vivus, obesity, Qsymia
BioDelivery Sciences on track to report data from two Phase 3 studies in 2014
Yahoo/Fly on the Wall
Friday, August 9, 2013 - 10:44am
tags:
BioDelivery Sciences, Bunavail, opioid addiction
Should You Keep an Eye on These Eye Treatment Biotechs?
Motley Fool
Friday, August 9, 2013 - 10:30am
tags:
wet age-related macular degeneration, diabetic macular edema, Lucentis, Novartis, Roche, Eylea, Regeneron, Optina, Ampio Pharmaceuticals
Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug
Fierce Biotech
Friday, August 9, 2013 - 10:00am
tags:
Ariad Pharmaceuticals, FDA, non-small cell lung cancer, AP26113
Synergy sees initiating phase 3 program for plecanatide in CIC in Q4
Yahoo/Fly on the Wall
Friday, August 9, 2013 - 9:46am
tags:
Synergy Pharmaceuticals, plecanatide, chronic idiopathic constipation
Amarin's Q2 Shows Large Losses, Prescription Progress
Seeking Alpha
Friday, August 9, 2013 - 9:45am
tags:
Amarin, earnings
Novo Nordisk Getting Its Trial By Fire
Investopedia
Friday, August 9, 2013 - 9:44am
tags:
earnings, Novo Nordisk, diabetes, Teva, Eli Lilly, Sanofi
Sun Pharmaceutical Profit Surges Before Pfizer Settlement Charge
Bloomberg
Friday, August 9, 2013 - 9:41am
tags:
Sun Pharma, earnings, Pfizer
Zogenix Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Friday, August 9, 2013 - 9:40am
tags:
earnings, Zogenix
Pharma professionals feeling angst, but see a few rays of hope
Fierce Pharma
Thursday, August 8, 2013 - 6:56pm
tags:
Big Pharma, patent cliff
Biogen Gains A Leg Up In Fiercely Competitive MS Field
Seeking Alpha
Thursday, August 8, 2013 - 6:54pm
tags:
BiogenIdec, MS, multiple sclerosis, Tecfidera
Medivation Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Thursday, August 8, 2013 - 6:52pm
tags:
earnings, Medivation
Multiple Parties Involved in Potential Onyx Sale, CEO Says
Bloomberg
Thursday, August 8, 2013 - 6:52pm
tags:
ONYX Pharmaceuticals, M&A, Amgen, Bayer
Dendreon says sales of prostate cancer therapy Provenge won't grow in 2013; shares fall
Yahoo/AP
Thursday, August 8, 2013 - 6:50pm
tags:
prostate cancer, Dendreon, Provenge
Impax Laboratories Earnings: Here’s Why Investors are Not Happy Now
Wall St. Cheat Sheet
Thursday, August 8, 2013 - 6:50pm
tags:
Impax Laboratories, earnings
Glaxo Invests in Bioelectronics With New Venture Fund
Bloomberg
Thursday, August 8, 2013 - 2:41pm
tags:
GSK, bioelectronics, venture funds
Former Biotech CEO Asks Supreme Court To Review Free Speech Rights
Pharmalot
Thursday, August 8, 2013 - 2:40pm
tags:
InterMune, idiopathic pulmonary fibrosis, free speech, Actimmune

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.